Implanet Scores FDA Clearance, CE Mark

May 24, 2016

Orthopedic implant developer Implanet has scooped up FDA clearance and CE mark approval for its Jazz Claw implant for treatment of complex degenerative pathologies, such as kyphosis, in adults.

The hybrid implant offers autostable posterior fixation, eliminating the drawbacks of traditional hook-and-screw fixations.

The implant broadens the company’s growing portfolio of products targeting adult degenerative deformities. — Anisa Jibrell


View today's stories